The Australian Government has invested more than $3.3 billion through four agreements to obtain sufficient COVID-19 vaccination doses.
- Pfizer/BioNTech: Initially ordered 10 million doses from overseas. But has now reserved another 20 million doses to be available in Oct-Dec 2021.
- Oxford/AstraZeneca: Ordered 3.8 million doses from overseas.
- Oxford/AstraZeneca: Will manufacture 50 million doses in Australia.
- Novavax: Will manufacture 51 million doses in Australia.
That adds up to 134.8 million doses, to be supplied in 2021/22, but only a few have been supplied so far.
As at 8th April 2021 about 840,000 doses have so far been administered in Australia.
Australia has also paid for more vaccines doses to be distributed to 94 lower-income countries, who are unable to finance their own supply.
It is highly likely that any excess vaccines will go to other nations, after all those in Australia have been vaccinated.